Literature DB >> 28556255

National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus.

Viktor Grut1, Lars Söderström1, Estelle Naumburg1,2.   

Abstract

AIM: The respiratory syncytial virus (RSV) is a leading cause of hospitalisation in infants. We investigated this risk in children with Down's syndrome under two years of age, adjusted for other known risk factors.
METHODS: This national, retrospective 1:2 matched cohort study comprised all Swedish children born with Down's from 2006 to 2011, who were each randomly matched to two controls without Down's. Data on RSV hospitalisation and risk factors for RSV were obtained from national registers. The risk of RSV hospitalisation was assessed using multivariable Cox regression with pairwise stratification.
RESULTS: The study comprised 814 children with Down's and 1628 controls. We found that 82 children with Down's (10.1%) and 22 controls (1.4%) were hospitalised for RSV. The hazard ratio for children with Down's was 4.00 (95% confidence interval 1.58-10.13) for up to one year of age and 6.60 (95% CI: 2.83-15.38) for up to two years of age, adjusted for other risk factors. During the second year of life, RSV hospitalisation continued for children with Down's, while it was minimal for the controls.
CONCLUSION: Children with Down's faced a high risk of RSV hospitalisation, which continued beyond the first year of age. ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Down's syndrome; Hospital admission; National registers; Respiratory syncytial virus; Risk factors

Mesh:

Year:  2017        PMID: 28556255     DOI: 10.1111/apa.13937

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

Review 1.  Down syndrome.

Authors:  Stylianos E Antonarakis; Brian G Skotko; Michael S Rafii; Andre Strydom; Sarah E Pape; Diana W Bianchi; Stephanie L Sherman; Roger H Reeves
Journal:  Nat Rev Dis Primers       Date:  2020-02-06       Impact factor: 52.329

2.  Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study.

Authors:  Yvette N Löwensteyn; Emily W E M Phijffer; Juliette V L Simons; Nienke M Scheltema; Natalie I Mazur; Harish Nair; Louis J Bont
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.